Mental Health Clinics in Broadheadsville, PA Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Open Door Workplace Counseling Initiatives Social Worker Medicare: Not Enrolled in Medicare Practice Location: 710 Frable Road, Broadheadsville, PA 18322 Phone: 570-764-4706 Fax: 570-402-2056 |
News Archive
Study: Gene variants linked with increased risk for kidney complications in patients with lupus
Variants in a particular gene are linked with an increased risk for kidney complications in patients with lupus, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The findings could lead to better treatments to protect the kidney health of patients with the disease.
Analysis finds untapped potential for immunotherapy in older cancer patients
A retrospective analysis of large datasets of biomarkers from tumors and healthy tissue by researchers at the Johns Hopkins Kimmel Cancer Center Convergence Institute suggests that older cancer patients could benefit as much as younger patients from cancer immunotherapies.
UVA researchers discover how obesity may trigger harmful inflammation
New research from the University of Virginia School of Medicine explains why obesity causes harmful inflammation that can lead to diabetes, clogged arteries and other health problems. Doctors may be able to use this knowledge to battle these chronic diseases and others driven by damaging inflammation.
Decision Resources: NSCLC drug market to grow from $4 billion in 2009 to over $6.5 billion in 2019
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that the non-small-cell lung cancer (NSCLC) drug market will increase from approximately $4 billion in 2009 to more than $6.5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Juvaris BioTherapeutics completes second close on its Series B equity financing
Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, announced that it has completed a second close on its Series B equity financing of up to $25 million. The additional equity investment came from an undisclosed strategic corporate investor who joins SV Life Sciences and Kleiner Perkins Caufield & Byers in the round.
› Verified 2 days ago